EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Factors for Discontinuation of Naldemedine Therapy in a Palliative Ward

Takaki Kanie, Tomohiro Mizuno, Takenao Koseki, Aya Hanamoto, Hiroko Sawano, Masako Tomida, Yukiko Kakumae, Takahiro Hayashi, Hiroshi Matsuoka, Masanobu Usui, Shigeki Yamada

In Vivo · 2025

DOI: 10.21873/invivo.13965 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift In Vivo, 2025. Verfasst von Takaki Kanie und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, Toyoake, Japan. Hauptthemen laut MEDLINE: Palliative Care, Naltrexone, Opioid-Induced Constipation, Narcotic Antagonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Palliative CareNaltrexoneOpioid-Induced ConstipationNarcotic AntagonistsHumansMaleFemaleAgedAnalgesics, OpioidMiddle AgedRetrospective StudiesC-Reactive ProteinAged, 80 and overProportional Hazards Models

Stichwörter der Autor:innen

C-reactive protein-to-albumin ratioNaldemedineopioid-induced constipationpalliative ward

Substanzen

Analgesics, OpioidNaltrexonenaldemedineC-Reactive ProteinNarcotic Antagonists

Autor:innen und Institutionen

  • Department of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, Toyoake, Japan.
  • Department of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, Toyoake, Japan; tomohiro.mizuno@fujita-hu.ac.jp.
  • College of Pharmacy, Kinjo Gakuin University, Nagoya, Japan.
  • Department of Surgery, Fujita Health University School of Medicine, Toyoake, Japan.
  • Department of Palliative Medicine, Fujita Health University Hospital, Toyoake, Japan.

Zitieren

APA

Kanie, T., Mizuno, T., Koseki, T., Hanamoto, A., Sawano, H., Tomida, M., Kakumae, Y., Hayashi, T., Matsuoka, H., Usui, M., & Yamada, S. (2025). Factors for Discontinuation of Naldemedine Therapy in a Palliative Ward. In Vivo. https://doi.org/10.21873/invivo.13965

Vancouver

Kanie T, Mizuno T, Koseki T, Hanamoto A, Sawano H, Tomida M, et al. Factors for Discontinuation of Naldemedine Therapy in a Palliative Ward. In Vivo. 2025. doi:10.21873/invivo.13965

BibTeX
@article{Kanie2025,
  author = {Kanie, Takaki and Mizuno, Tomohiro and Koseki, Takenao and Hanamoto, Aya and Sawano, Hiroko and Tomida, Masako and Kakumae, Yukiko and Hayashi, Takahiro and Matsuoka, Hiroshi and Usui, Masanobu and Yamada, Shigeki},
  title = {Factors for Discontinuation of Naldemedine Therapy in a Palliative Ward},
  journal = {In Vivo},
  year = {2025},
  doi = {10.21873/invivo.13965}
}
Kostenlos starten →